Daniels, R.W. et al. Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J. Neurosci. 24, 10466-10474

Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.34). 12/2004; 24(46):10466-74. DOI: 10.1523/JNEUROSCI.3001-04.2004
Source: PubMed


Quantal size is a fundamental parameter controlling the strength of synaptic transmission. The transmitter content of synaptic vesicles is one mechanism that can affect the physiological response to the release of a single vesicle. At glutamatergic synapses, vesicular glutamate transporters (VGLUTs) are responsible for filling synaptic vesicles with glutamate. To investigate how VGLUT expression can regulate synaptic strength in vivo, we have identified the Drosophila vesicular glutamate transporter, which we name DVGLUT. DVGLUT mRNA is expressed in glutamatergic motoneurons and a large number of interneurons in the Drosophila CNS. DVGLUT protein resides on synaptic vesicles and localizes to the presynaptic terminals of all known glutamatergic neuromuscular junctions as well as to synapses throughout the CNS neuropil. Increasing the expression of DVGLUT in motoneurons leads to an increase in quantal size that is accompanied by an increase in synaptic vesicle volume. At synapses confronted with increased glutamate release from each vesicle, there is a compensatory decrease in the number of synaptic vesicles released that maintains normal levels of synaptic excitation. These results demonstrate that (1) expression of DVGLUT determines the size and glutamate content of synaptic vesicles and (2) homeostatic mechanisms exist to attenuate the excitatory effects of excess glutamate release.

Download full-text


Available from: Richard W Daniels, Jun 20, 2014
  • Source
    • "Flies expressing E1 RNAi and DVMAT-pHluorin were generated as described in (Martin et al., 2014) and (Grygoruk et al., 2014), respectively, and are available on request. Other lines including elav-GAL4(X) (Robinow and White, 1991), Tdc2-GAL4 (Cole et al., 2005), DVGLUT-GAL4 (Daniels et al., 2004), UAS-Arclight (Cao et al., 2013) and UAS- GCaMP6m(III) (Chen et al., 2013) are available from the "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple populations of aminergic neurons are affected in Parkinson's disease (PD), with serotonergic and noradrenergic loci responsible for some non-motor symptoms. Environmental toxins, such as the dithiocarbamate fungicide ziram, significantly increase the risk of developing PD and the attendant spectrum of both motor and non-motor symptoms. The mechanisms by which ziram and other environmental toxins increase the risk of PD, and the potential effects of these toxins on aminergic neurons, remain unclear. To determine the relative effects of ziram on the synaptic function of aminergic versus non-aminergic neurons, we used live-imaging at the Drosophila melanogaster larval neuromuscular junction (NMJ). In contrast to nearly all other studies of this model synapse, we imaged presynaptic function at both glutamatergic Type Ib and aminergic Type II boutons, the latter responsible for storage and release of octopamine, the invertebrate equivalent of noradrenalin. To quantify the kinetics of exo- and endo- cytosis, we employed an acid-sensitive form of GFP fused to the Drosophila vesicular monoamine transporter (DVMAT-pHluorin). Additional genetic probes were used to visualize intracellular calcium flux (GCaMP) and voltage changes (ArcLight). We find that at glutamatergic Type Ib terminals, exposure to ziram increases exocytosis and inhibits endocytosis. By contrast, at octopaminergic Type II terminals, ziram has no detectable effect on exocytosis and dramatically inhibits endocytosis. In contrast to other reports on the neuronal effects of ziram, these effects do not appear to result from perturbation of the UPS or calcium homeostasis. Unexpectedly, ziram also caused spontaneous and synchronized bursts of calcium influx (measured by GCaMP) and electrical activity (measured by ArcLight) at aminergic Type II, but not glutamatergic Type Ib, nerve terminals. These events are sensitive to both tetrodotoxin and cadmium chloride, and thus appear to represent spontaneous depolarizations followed by calcium influx into Type II terminals. We speculate that the differential effects of ziram on Type II versus Type Ib terminals may be relevant to the specific sensitivity of aminergic neurons in PD, and suggest that changes neuronal excitability could contribute to the increased risk for PD caused by exposure to ziram. We also suggest that the fly NMJ will be useful to explore the synaptic effects of other pesticides associated with an increased risk of PD.
    Experimental Neurology 10/2015; DOI:10.1016/j.expneurol.2015.09.017 · 4.70 Impact Factor
    • "The vesicular glutamate transporters are important for the storage and release of the excitatory neurotransmitter glutamate at presynaptic axon terminals (Ni et al. 1994; Bellocchio et al. 2000; Takamori et al. 2000; Herzog et al. 2001; Gras et al. 2002; Schäfer et al. 2002). In addition to a third subtype (VGLUT-3), they belong to the Slc17 family (solute carrier family) of proteins which are highly conserved in nature and found in organisms as diverse as drosophila, zebra fish, frogs, and mammals (Daniels et al. 2004; Higashijima et al. 2004, Gleason et al. 2003). The presence of the vesicular glutamate transporters is an important diagnostic for identifying glutamatergic synapses and therefore, for excitatory projections in the brain. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We had earlier demonstrated a neurofilament-rich plexus of axons in the presumptive human auditory cortex during fetal development which became adult-like during infancy. To elucidate the origin of these axons, we studied the expression of the vesicular glutamate transporters (VGLUT) 1 and 2 in the human auditory cortex at different stages of development. While VGLUT-1 expression predominates in intrinsic and cortico-cortical synapses, VGLUT-2 expression predominates in thalamocortical synapses. Levels of VGLUT-2 mRNA were higher in the auditory cortex before birth compared to postnatal development. In contrast, levels of VGLUT-1 mRNA were low before birth and increased during postnatal development to peak during childhood and then began to decrease in adolescence. Both VGLUT-1 and VGLUT-2 proteins were present in the human auditory cortex as early as 15GW. Further, immunohistochemistry revealed that the supra- and infragranular layers were more immunoreactive for VGLUT-1 compared to that in Layer IV at 34GW and this pattern was maintained until adulthood. As for VGLUT-1 mRNA, VGLUT-1 synapses increased in density between prenatal development and childhood in the human auditory cortex after which they appeared to undergo attrition or pruning. The adult pattern of VGLUT-2 immunoreactivity (a dense band of VGLUT-2-positive terminals in Layer IV) also began to appear in the presumptive Heschl's gyrus at 34GW. The density of VGLUT-2-positive puncta in Layer IV increased between prenatal development and adolescence, followed by a decrease in adulthood, suggesting that thalamic axons which innervate the human auditory cortex undergo pruning comparatively late in development.
    Brain Structure and Function 10/2015; DOI:10.1007/s00429-015-1124-6 · 5.62 Impact Factor
    • "Impairment of CB 1 R signaling affects the neuronal excitatory/inhibitory balance with effects on emotional function and anxiety-or depressive-like behaviors (Chiba et al., 2012; den Boon et al., 2014; Prager et al., 2014). Anxiety can be modulated by eCB in a bimodal way through the activation of different subsets of CB 1 R at excitatory/VGluT1-or inhibitory/VGAT-positive inputs (Ruehle et al., 2012), which, in turn, can affect the VGluT1 or VGAT presynaptic density and their vesicular quantal size (Daniels et al., 2004; Wilson et al., 2005). These alterations play a key role in the etiology of anxiety-like behaviors when occurring in PFC, amygdala and hippocampal circuits (Chiba et al., 2012; Prager et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Endocannabinoids (eCB) are key regulators of excitatory/inhibitory neurotransmission at cannabinoid-1-receptor (CB1R)-expressing axon terminals. The most abundant eCB in the brain, that is 2-arachidonoylglycerol (2-AG), is hydrolyzed by the enzyme monoacylglycerol lipase (MAGL), whose chronic inhibition in the brain was reported to cause CB1R desensitization. We employed the MAGL knock-out mice (MAGL-/-), a genetic model of congenital and sustained elevation of 2-AG levels in the brain, to provide morphological and biochemical evidence for β-arrestin2-mediated CB1R desensitization in brain regions involved in the control of emotional states, that is, the prefrontal cortex (PFC), amygdala, hippocampus and cerebellar cortex. We found a widespread CB1R/β-arrestin2 co-expression in the mPFC, amygdala and hippocampus accompanied by impairment of ERK signaling and elevation of vesicular glutamate transporter (VGluT1) at CB1R-positive excitatory terminals in the mPFC, or vesicular GABA transporter (VGAT) at CB1R-positive inhibitory terminals in the amygdala and hippocampus. The impairment of CB1R signaling in MAGL-/- mice was also accompanied by enhanced excitatory drive in the BLA-mPFC circuit, with subsequent elevation of glutamate release to the mPFC and anxiety-like behavior, as assessed by the marble burying test. Collectively, these data provide evidence for a β-arrestin2-mediated desensitization of CB1R in MAGL-/- mice, with impact on the synaptic plasticity of brain circuits involved in emotional functions. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
    Journal of Neurochemistry 07/2015; DOI:10.1111/jnc.13267 · 4.28 Impact Factor
Show more